Secora Michael
SEC CIK 1855980 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | CFO | 1.49M | — | $6.40M | 53 | 2022-02-04 | 2024-11-15 |
Most active insiders at RXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Borgeson Blake | Dir | — | $4.10M |
| 2 | Gibson Christopher | Dir | — | $3.84M |
| 3 | Khan Najat | Chief R, D Commercial Off, Dir | — | $806.7K |
| 4 | Taylor Ben R | CFO | — | $157.7K |
| 5 | Bumpus Namandje | Dir | — | $28.1K |
| 6 | Michor Franziska | Dir | — | — |
| 7 | Hallett David | CSO | — | — |
| 8 | Dar Zavain | Dir | — | — |
| 9 | Li Dean Y | Dir | — | — |
| 10 | Sun Elaine D | Dir | — | — |
Secora Michael made no open-market trades at RXRX in the last 12 months.
Transactions 53
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-19 | 2024-11-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $6.18 | -11.9K | 1.49M | -0.8% | -$73.8K | |
| DM | 2024-11-14 | 2024-11-12+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +78.8K | 1.51M | +5% | +$174.8K |
| DM | 2024-11-14 | 2024-11-12+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $7.65 | -30.0K | 1.48M | -2% | -$229.5K |
| DM | 2024-10-10 | 2024-10-08+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +78.8K | 1.44M | +6% | +$174.8K |
| DM | 2024-10-10 | 2024-10-08+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $6.34 | -30.0K | 1.45M | -2% | -$190.2K |
| DM | 2024-09-12 | 2024-09-10+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $6.25 | -30.0K | 1.38M | -2% | -$187.3K |
| DM | 2024-09-12 | 2024-09-10+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +78.8K | 1.39M | +6% | +$174.8K |
| 2024-08-19 | 2024-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $6.69 | -12.0K | 1.35M | -0.9% | -$80.0K | |
| DM | 2024-08-15 | 2024-08-13+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +78.8K | 1.38M | +6% | +$174.8K |
| DM | 2024-08-15 | 2024-08-13+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $6.35 | -30.0K | 1.34M | -2% | -$190.5K |
| DM | 2024-07-11 | 2024-07-09+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +78.8K | 1.33M | +6% | +$174.8K |
| DM | 2024-07-11 | 2024-07-09+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $7.28 | -30.0K | 1.32M | -2% | -$218.4K |
| DM | 2024-06-17 | 2024-06-13+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $9.29 | -30.0K | 1.27M | -2% | -$278.9K |
| DM | 2024-06-17 | 2024-06-13+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +78.8K | 1.26M | +7% | +$174.8K |
| 2024-05-17 | 2024-05-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $10.01 | -12.0K | 1.22M | -1.0% | -$119.7K | |
| DM | 2024-04-18 | 2024-04-16+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $7.63 | -48.1K | 1.22M | -4% | -$367.0K |
| DM | 2024-04-18 | 2024-04-16+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 1.24M | +6% | +$166.5K |
| DM | 2024-03-14 | 2024-03-12+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $10.74 | -50.0K | 1.19M | -4% | -$537.2K |
| DM | 2024-03-14 | 2024-03-12+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 1.22M | +7% | +$166.5K |
| 2024-02-16 | 2024-02-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $12.43 | -7,172 | 1.18M | -0.6% | -$89.1K | |
| DM | 2024-02-15 | 2024-02-13+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $10.16 | -50.0K | 1.19M | -4% | -$507.8K |
| DM | 2024-02-15 | 2024-02-13+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 1.20M | +7% | +$166.5K |
| D | 2024-02-13 | 2024-02-09 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $10.09 | -2,512 | 1.16M | -0.2% | -$25.3K |
| DM | 2024-02-13 | 2024-02-09 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | A - Grant | $0.00 | +182.8K | 989.7K | +23% | $0 |
| DM | 2024-01-18 | 2024-01-16+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 1.01M | +8% | +$166.5K |
| DM | 2024-01-18 | 2024-01-16+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $10.35 | -50.0K | 981.0K | -5% | -$517.5K |
| DM | 2023-12-14 | 2023-12-12+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $7.49 | -50.0K | 943.5K | -5% | -$374.5K |
| DM | 2023-12-14 | 2023-12-12+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 981.0K | +8% | +$166.5K |
| DM | 2023-11-16 | 2023-11-14+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 963.2K | +8% | +$166.5K |
| DM | 2023-11-16 | 2023-11-14+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $6.82 | -50.0K | 938.2K | -5% | -$341.0K |
| D | 2023-11-16 | 2023-11-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $7.18 | -7,172 | 931.0K | -0.8% | -$51.5K |
| DM | 2023-10-12 | 2023-10-10+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 938.2K | +9% | +$166.5K |
| DM | 2023-10-12 | 2023-10-10+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $6.96 | -50.0K | 900.7K | -5% | -$348.0K |
| DM | 2023-09-14 | 2023-09-12+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 913.2K | +9% | +$166.5K |
| DM | 2023-09-14 | 2023-09-12+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $8.56 | -50.0K | 888.2K | -5% | -$428.0K |
| DM | 2023-08-17 | 2023-08-15+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 875.7K | +9% | +$166.5K |
| DM | 2023-08-17 | 2023-08-15+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $9.09 | -50.0K | 850.7K | -6% | -$454.3K |
| D | 2023-08-17 | 2023-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $9.19 | -4,727 | 838.2K | -0.6% | -$43.4K |
| DM | 2023-07-19 | 2023-07-18+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 855.4K | +10% | +$166.5K |
| DM | 2023-07-19 | 2023-07-18+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $14.58 | -50.0K | 830.9K | -6% | -$729.0K |
| DM | 2023-06-15 | 2023-06-13+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 842.9K | +10% | +$166.5K |
| DM | 2023-06-15 | 2023-06-13+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | S - Sale+OE | $10.00 | -50.0K | 817.9K | -6% | -$500.0K |
| 2023-05-17 | 2023-05-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $5.60 | -4,760 | 790.2K | -0.6% | -$26.7K | |
| A | 2023-04-28 | 2022-02-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $11.40 | -678 | 590.4K | -0.1% | -$7,729 |
| MA | 2023-04-28 | 2022-02-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | A - Grant | $0.00 | +60.3K | 591.1K | +11% | $0 |
| 2023-02-17 | 2023-02-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $8.44 | -1,258 | 794.3K | -0.2% | -$10.6K | |
| DM | 2023-02-03 | 2023-02-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | A - Grant | $0.00 | +210.2K | 790.5K | +36% | $0 |
| D | 2023-02-03 | 2023-02-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $8.55 | -2,669 | 795.6K | -0.3% | -$22.8K |
| 2022-11-17 | 2022-11-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $11.86 | -1,065 | 586.6K | -0.2% | -$12.6K | |
| 2022-08-17 | 2022-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $12.96 | -1,065 | 587.6K | -0.2% | -$13.8K | |
| 2022-05-18 | 2022-05-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $5.67 | -1,069 | 588.7K | -0.2% | -$6,061 | |
| DM | 2022-02-08 | 2022-02-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | A - Grant | $0.00 | +60.3K | 590.4K | +11% | $0 |
| D | 2022-02-08 | 2022-02-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Secora Michael | CFO | F - Tax | $11.40 | -678 | 589.8K | -0.1% | -$7,729 |
Purchase Sale Sale after option exercise All abbreviations